SAFETY AND ANTIVIRAL ACTIVITY OF BI201335, A NEW HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 INFECTION GIVEN AS MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA 2A (P) AND RIBAVIRIN (R)

被引：0

作者：

Manns, Michael P. ^{[1
]}

Bourliere, Marc ^{[2
]}

Benhamou, Yves ^{[3
]}

Pol, Stanislas ^{[8
]}

Bonacini, Maurizio ^{[4
]}

Berg, Thomas ^{[5
]}

Trepo, Christian ^{[6
]}

Wright, David ^{[7
]}

Steinmann, Gerhard ^{[9
]}

Huang, David B. ^{[9
]}

Mikl, Jaromir ^{[9
]}

Kukolj, George ^{[9
]}

Stern, Jerry O. ^{[9
]}

机构：

[1] Hannover Med Sch, Zentrum Innere Med, Hannover, Germany

[2] Hop St Joseph, Marseille, France

[3] Hop La Pitie Salpetriere, Paris, France

[4] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA

[5] Charite Berlin Campus Virchow Klinikum, Berlin, Germany

[6] Hop Hotel Dieu, F-69288 Lyon, France

[7] Cent Texas Clin Res, Austin, TX USA

[8] Hop Cochin, F-75674 Paris, France

[9] Boehringer Ingelheim Pharma GmbH & Co KG, Ridgefield, CT USA

来源：

HEPATOLOGY | 2008年 / 48卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1849

引用

页码：1133A / 1133A

页数：1

共 50 条

[1] SAFETY AND ANTIVIRAL ACTIVITY OF BI201335, A NEW HCV NS3 PROTEASE INHIBITOR, IN COMBINATION THERAPY WITH PEGINTERFERON ALFA 2A (P) AND RIBAVIRIN (R) FOR 28 DAYS IN P+R TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS GENOTYPE-1 INFECTION
Manns, Michael P.
Bourliere, Marc
Benhamou, Yves
Schuchmann, Marcus
Haussinger, Dieter
Pol, Stanislas
Bonacini, Maurizio
Calleja, Jose L.
Steinmann, Gerhard
Huang, David B.
Mikl, Jaromir
Kukolj, George
Stern, Jerry O.
[J]. HEPATOLOGY, 2008, 48 (04) : 1151A - 1152A
[2] SILEN-C3: TREATMENT FOR 12 OR 24 WEEKS WITH BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAiVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION
Dieterich, Douglas
Asselah, Tarik
Guyader, Dominique
Berg, Thomas
Ceausu, Emanoil
Preotescu, Liliana
Schuchmann, Marcus
Mauss, Stefan
Ratziu, Vlad
Ferenci, Peter
Larrey, Dominique G.
Maieron, Andreas
Biermer, Michael
Stern, Jerry O.
Scherer, Joe
Kubiak, Rene
Boecher, Wulf O.
[J]. HEPATOLOGY, 2011, 54 : 378A - 378A
[3] Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
Manns, Michael P.
Bourliere, Marc
Benhamou, Yves
Pol, Stanislas
Bonacini, Maurizio
Trepo, Christian
Wright, David
Berg, Thomas
Calleja, Jose L.
White, Peter W.
Stern, Jerry O.
Steinmann, Gerhard
Yong, Chan-Loi
Kukolj, George
Scherer, Joe
Boecher, Wulf O.
[J]. JOURNAL OF HEPATOLOGY, 2011, 54 (06) : 1114 - 1122
[4] BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN
Kukolj, G.
Benhamou, Y.
Manns, M. P.
Bourliere, M.
Pol, S.
Schuchmann, M.
Cartier, M.
Huang, D.
Lagace, L.
Steinmann, G.
Stern, J. O.
[J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S347 - S347
[5] SILEN-C1: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAiVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
Sulkowski, Mark S.
Ferenci, Peter
Emanoil, Ceausu
Asselah, Tarik
Caruntu, Florin
Lalezari, Jay
Bourliere, Marc
Mauss, Stefan
Grange, Jean-Didier
Berg, Thomas
Zeuzem, Stefan
Streinu-Cercel, Adrian
Wright, David
Jensen, Donald M.
Haefner, Carla
Datsenko, Yakiv
Stern, Jerry O.
Nehmiz, Gerhard
Steinmann, Gerhard
[J]. HEPATOLOGY, 2009, 50 (06) : 2A - 2A
[6] SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
Sulkowski, M. S.
Ceasu, E.
Asselah, T.
Caruntu, F. A.
Lalezari, J.
Ferenci, P.
Streinu-Cercel, A.
Fainboim, H.
Tanno, H.
Preotescu, L.
Leggett, B.
Bessone, F.
Mauss, S.
Stern, J. O.
Haefner, C.
Datsenko, Y.
Nehmiz, G.
Boecher, W.
Steinmann, G.
[J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S27 - S27
[7] ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION
Bronowicki, J-P
Pol, S.
Thuluvath, P.
Larrey, D.
Martorell, C. T.
Rustgi, V. K.
Morris, D. W.
Younes, Z.
Fried, M. W.
Bourliere, M.
Hezode, C.
Reddy, R.
Massoud, O.
Abrams, G. A.
Ratziu, V.
He, B.
Eley, T.
Ahmad, A.
Thiry, A.
Llamoso, C.
Mendez, P.
Hughes, E.
[J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S431 - S432
[8] VIROLOGICAL RESPONSE AND SAFETY OF BI 201335 PROTEASE INHIBITOR, PEGINTERFERON ALFA 2A AND RIBAVIRIN TREATMENT OF HCV GENOTYPE-1 PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND NON-RESPONSE TO PREVIOUS PEGINTERFERON RIBAVIRIN
Pol, Stanislas
Berg, Thomas
Bonacini, Maurizio
Schuchmann, Marcus
Lalezari, Jay
Erhardt, Andreas
Bourliere, Marc
Manns, Michael P.
Yong, Chan L.
Steinmann, Gerhard
Stern, Jerry O.
Scherer, Joe
Boecher, Wolf O.
[J]. HEPATOLOGY, 2009, 50 (06) : 10A - 11A
[9] SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R
Sulkowski, M. S.
Bourliere, M.
Bronowicki, J. -P.
Streinu-Cercel, A.
Preotescu, L.
Asselah, T.
Pawlotsky, J. -M.
Shafran, S.
Pol, S.
Caruntu, F. A.
Mauss, S.
Larrey, D.
Haefner, C.
Datsenko, Y.
Stern, J. O.
Kubiak, R.
Boecher, W.
Steinmann, G.
[J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S30 - S30
[10] BMS-650032, AN NS3 INHIBITOR, IN COMBINATION WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION
Bronowicki, J. -P.
Pol, S.
Thuluvath, P. J.
Larrey, D.
Martorell, C. T.
Rustgi, V. K.
Morris, D. W.
Younes, Z.
Fried, M. W.
Bourliere, M.
Hezode, C.
Massoud, O.
Abrams, G. A.
Ratziu, V.
Thiry, A.
Llamoso, C.
Hughes, E. A.
Hindes, R. G.
[J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S472 - S472

← 1 2 3 4 5 →